Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. 4 July 2019. Walban Damasceno de Souza.

Executive Summary

Anvisa – Brazil's medical technology regulatory agency – has enacted a regulation that allows new devices that are sterilized using ethylene oxide to be certified as sterile under a parametric release protocol. See what Walban Damasceno de Souza of medtech industry association ABIMO said about it here.

“This is a great victory for our industry, which has been suffering from outdated legislation, compared with most other countries. All companies, from the largest, with their own sterilization facilities, to the smallest, which rely on outsourced services, will benefit immediately.” – Walban Damasceno de Souza, senior adviser, ABIMO

Click here for a free trial of Medtech Insight


Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts